Centessa Pharmaceuticals plc (CNTA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -72.22M | -55.81M | -58.31M | -22.45M | -57.25M | -42.8M | -21.39M | -40.58M | -37.29M | -31.1M | -37.39M | -44.06M | -47.84M | -51.56M | -39.09M | -59.88M | -50.02M | -56.29M | -33.32M | -33.87M |
| Operating CF Margin % | - | - | - | - | -381.64% | - | - | - | - | -453.82% | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -26.16% | -30.39% | -172.63% | 44.67% | -53.53% | -37.62% | 42.8% | 7.9% | 22.06% | 39.69% | 4.34% | 26.41% | 4.36% | 8.39% | -17.31% | -76.8% | -294.9% | -1615.61% | - | - |
| Net Income | -79.24M | -66.16M | -54.89M | -50.34M | -26.14M | -111.33M | -42.57M | -43.82M | -38.05M | -37.16M | -38.65M | -24.89M | -50.71M | -43.17M | -53.88M | -64.66M | -54.5M | -60.91M | -39.97M | -41.37M |
| Depreciation & Amortization | 239K | 241K | 237K | 226K | 217K | 227.87K | 236K | 236K | 240K | 248.14K | 238K | 237K | 89K | 36K | 35K | 32K | 28K | 12.01K | 12.94K | 0 |
| Stock-Based Compensation | 10.56M | 7.94M | 7.19M | 7.95M | 7.88M | 8.33M | 8.45M | 8.61M | 8.15M | 7.43M | 7.56M | 7.21M | 7.19M | 6.62M | 7.03M | 5.6M | 5.72M | 0 | 0 | 0 |
| Deferred Taxes | 828K | 233K | 255K | 1.03M | 995K | 388.98K | 1.25M | 567K | 434K | -135.33K | -2.89M | -23.49M | 0 | 0 | -135K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.15M | 21.93M | 157K | 137K | -1.67M | 34.39M | -570K | -290.05K | 1.1M | 1.96M | 795K | 1.7M | 1.8M | -1M | 800K | -7.35M | 1.08M | 6.55M | 6.78M | 14.48M |
| Working Capital Changes | -5.76M | -19.99M | -11.26M | 18.55M | -38.54M | 25.2M | 11.8M | -5.89M | -9.17M | -3.45M | -4.45M | -4.84M | -6.2M | -14.04M | 7.06M | 6.5M | -2.35M | -1.94M | -138.49K | -6.98M |
| Change in Receivables | -3.61M | 6.45M | -9.98M | 10.73M | -4.28M | -12.1M | 9.84M | 0 | 1.21M | -7.96M | -2.33M | -6.14M | 4.31M | -3.86M | -2.55M | 428K | -5.73M | 3.48M | -5.09M | -3.26M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.26M | -1.31M | 3.28M | 177K | -2.1M | 143K | 1.71M | -2.19M | -4.25M | 590.06K | 83K | -1.58M | -1.81M | 2.6M | 3.13M | 1.84M | -1.22M | 0 | 0 | 0 |
| Cash from Investing | 42.71M | -218.13M | 61.95M | -39.95M | -222.39M | 25M | 44.96M | -55.46M | 16.76M | -18.29M | 48.71M | -71.1M | -86.34M | -446K | -16K | -229K | -240K | -217.44K | 51.57K | -322.74K |
| Capital Expenditures | 0 | -11K | -234K | -126K | 0 | 139 | -34K | 2 | 0 | -28.03K | -43K | -10K | -88K | -652K | -16K | -229K | -240K | -63.7K | -48.23K | -36.92K |
| CapEx % of Revenue | - | - | - | - | 0% | - | - | - | - | 0.41% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.25M | -86.63M | 0 | 0 | 0 | 0 | 0 | 0 | -153.75K | 99.8K | -285.81K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -75.09M | 0 | 0 | -75.09M | 15.01K | -146.83M | -52.91K | 0 | -18.25M | 86.25M | 0 | 0 | 206K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 30.47M | 283.4M | 3.44M | 1.6M | 3.09M | 2.96M | 245.98M | 105.31M | 10.49M | 6.38M | 14.74M | 12K | 0 | 89K | 224K | 70K | 74K | 73M | -1.07M | 345.41M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -762.32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73.64M | 0 | 0 |
| Equity Issued (Net) | 34.06M | 9.66M | 3.53M | 1.76M | 7.9M | -30K | 242.71M | 107.27M | 9.65M | 6.24M | 14.56M | 0 | 0 | 0 | 0 | 0 | 0 | -933.24K | -776.39K | 345.41M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 | -19 | -12.01K |
| Other Financing | -3.6M | 273.74M | -101.05K | -152.09K | -4.82M | 3.76M | 3.27M | -1.96M | 838K | 118K | 180K | 12K | 0 | 89K | 224K | 70K | 74K | 295.68K | -295.68K | 0 |
| Net Change in Cash | 1.13M | 11.14M | 6.57M | -60.91M | -278.06M | -11.8M | 267.65M | 9.15M | -9.81M | -43.47M | 26.28M | -114.77M | -133.66M | -51.2M | -39.32M | -60.3M | -50.62M | 16.27M | -34.94M | 315.15M |
| Free Cash Flow | -72.22M | -55.82M | -58.55M | -22.58M | -57.25M | -42.8M | -21.42M | -40.58M | -37.29M | -31.13M | -37.44M | -44.07M | -47.93M | -52.22M | -39.1M | -60.11M | -50.26M | -56.35M | -33.37M | -33.9M |
| FCF Margin % | - | - | - | - | -381.64% | - | - | - | - | -454.23% | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -26.16% | -30.42% | -173.29% | 44.36% | -53.53% | -37.49% | 42.77% | 7.92% | 22.2% | 40.38% | 4.27% | 26.68% | 4.64% | 7.34% | -17.19% | -77.28% | -295.64% | -1617.55% | - | - |
| FCF per Share | -0.47 | -0.41 | -0.44 | -0.17 | -0.43 | -0.32 | -0.18 | -0.37 | -0.37 | -0.32 | -0.39 | -0.46 | -0.50 | -0.55 | -0.41 | -0.64 | -0.56 | -0.63 | -0.37 | -0.53 |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.84x | 1.06x | 0.45x | 2.19x | 0.38x | 0.50x | 0.93x | 0.98x | 0.84x | 0.97x | 1.77x | 0.94x | 1.19x | 0.73x | 0.93x | 0.92x | - | 0.83x | 0.82x |
| Interest Paid | 0 | 0 | 2.62M | 2.62M | 0 | 2.47M | 2.56M | 2.52M | 2.53M | 2.57M | 2.54M | 2.45M | 2.34M | 2.2M | 1.92M | 1.65M | 1.5M | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 113K | 990K | 0 | -11K | 10K | 1K | 0 | -4K | 241K | 2.57M | 135K | 437K | 0 | 862K | 0 | 0 | 0 | 0 |